Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NATCO Pharma Limited ( (IN:NATCOPHARM) ) has shared an update.
Natco Pharma Limited has announced the publication of its 42nd Annual General Meeting details in prominent newspapers, Financial Express and Nava Telangana, as part of regulatory compliance. This announcement underscores the company’s commitment to transparency and adherence to regulatory requirements, which may enhance its reputation among stakeholders and investors.
More about NATCO Pharma Limited
Natco Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of generic medicines. The company is known for its expertise in oncology and specialty pharmaceuticals, serving markets across the globe.
Average Trading Volume: 74,333
Technical Sentiment Signal: Sell
Current Market Cap: 154.3B INR
Find detailed analytics on NATCOPHARM stock on TipRanks’ Stock Analysis page.